Artwork

Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep68: The Future of Mental Health Care

35:32
 
Share
 

Manage episode 365914470 series 2857558
Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, we hear from Jenna Carl PhD, Chief Medical Officer at Big Health. Big Health believes in mental health care for all and that their digital therapeutics are safe and effective non-drug options for mental health.

In this episode, we cover:

  • Consumer Experience with Sleepio vs Daylight: Gain insights into the end consumer experience and how these solutions are designed to improve sleep and mental well-being.
  • Go-to-Market Strategy: Explore Big Health's go-to-market strategy, and activating employers to reach upstream employees and achieve high engagement rates.
  • Deep Dive into the Relationship with CVS: Gain a deeper understanding of Big Health's relationship with CVS, specifically regarding medication targeting.
  • Abandoning Direct-to-Consumer (DTC): Uncover the reasons behind Big Health's decision to shift away from a direct-to-consumer approach and explore the implications of this strategic shift.
  • Clinical Evidence and Decision-making Processes: Learn about Big Health's extensive clinical study basis and the rationale behind this approach.
  • Future Product Pipeline: Gain insights into Big Health's future plans for additional products and the exciting developments in their pipeline.
  • Big Health and Pear's Differing Go-To-Market Strategies: Explore the differing go-to-market routes between Big Health and Pear Therapeutics
  • Stand-alone DTx vs. Disease Management 2.0: Understand the merits and challenges of stand-alone digital therapeutics versus disease management 2.0

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

102 episodes

Artwork
iconShare
 
Manage episode 365914470 series 2857558
Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, we hear from Jenna Carl PhD, Chief Medical Officer at Big Health. Big Health believes in mental health care for all and that their digital therapeutics are safe and effective non-drug options for mental health.

In this episode, we cover:

  • Consumer Experience with Sleepio vs Daylight: Gain insights into the end consumer experience and how these solutions are designed to improve sleep and mental well-being.
  • Go-to-Market Strategy: Explore Big Health's go-to-market strategy, and activating employers to reach upstream employees and achieve high engagement rates.
  • Deep Dive into the Relationship with CVS: Gain a deeper understanding of Big Health's relationship with CVS, specifically regarding medication targeting.
  • Abandoning Direct-to-Consumer (DTC): Uncover the reasons behind Big Health's decision to shift away from a direct-to-consumer approach and explore the implications of this strategic shift.
  • Clinical Evidence and Decision-making Processes: Learn about Big Health's extensive clinical study basis and the rationale behind this approach.
  • Future Product Pipeline: Gain insights into Big Health's future plans for additional products and the exciting developments in their pipeline.
  • Big Health and Pear's Differing Go-To-Market Strategies: Explore the differing go-to-market routes between Big Health and Pear Therapeutics
  • Stand-alone DTx vs. Disease Management 2.0: Understand the merits and challenges of stand-alone digital therapeutics versus disease management 2.0

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

102 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide